1. Home
  2. CORT vs AES Comparison

CORT vs AES Comparison

Compare CORT & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • AES
  • Stock Information
  • Founded
  • CORT 1998
  • AES 1981
  • Country
  • CORT United States
  • AES United States
  • Employees
  • CORT N/A
  • AES N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • AES Electric Utilities: Central
  • Sector
  • CORT Health Care
  • AES Utilities
  • Exchange
  • CORT Nasdaq
  • AES Nasdaq
  • Market Cap
  • CORT 8.8B
  • AES 10.3B
  • IPO Year
  • CORT N/A
  • AES 1991
  • Fundamental
  • Price
  • CORT $76.11
  • AES $14.35
  • Analyst Decision
  • CORT Strong Buy
  • AES Hold
  • Analyst Count
  • CORT 4
  • AES 9
  • Target Price
  • CORT $139.00
  • AES $13.75
  • AVG Volume (30 Days)
  • CORT 964.5K
  • AES 12.7M
  • Earning Date
  • CORT 10-29-2025
  • AES 11-04-2025
  • Dividend Yield
  • CORT N/A
  • AES 4.92%
  • EPS Growth
  • CORT N/A
  • AES 8.40
  • EPS
  • CORT 1.11
  • AES 1.28
  • Revenue
  • CORT $716,080,000.00
  • AES $12,032,000,000.00
  • Revenue This Year
  • CORT $30.77
  • AES $2.67
  • Revenue Next Year
  • CORT $37.75
  • AES $4.34
  • P/E Ratio
  • CORT $67.64
  • AES $11.18
  • Revenue Growth
  • CORT 25.71
  • AES N/A
  • 52 Week Low
  • CORT $42.01
  • AES $9.46
  • 52 Week High
  • CORT $117.33
  • AES $17.67
  • Technical
  • Relative Strength Index (RSI)
  • CORT 44.32
  • AES 54.39
  • Support Level
  • CORT $69.43
  • AES $14.05
  • Resistance Level
  • CORT $80.29
  • AES $14.79
  • Average True Range (ATR)
  • CORT 4.31
  • AES 0.45
  • MACD
  • CORT -1.16
  • AES -0.02
  • Stochastic Oscillator
  • CORT 30.97
  • AES 23.05

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: